Israel Englander’s Applied Therapeutics APLT Stock Holding History

Israel Englander’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-100,000	Closed	-$850K	–	5927
2024 Q3	$850K	Buy	+100,000	New	+$589K	﹤0.01%	4401
2022 Q1	–	Sell	-54,600	Closed	-$489K	–	6870
2021 Q4	$489K	Buy	+54,600	New	+$717K	﹤0.01%	5064

Israel Englander's APLT Position: Q1 2026 in Review

Israel Englander sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 1,051,846 shares — an estimated $105K sold.

Israel Englander first reported a position in APLT in Q2 2019 and held it in 24 quarters. The position peaked at $6.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Israel Englander reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Israel Englander sold 1,051,846 Applied Therapeutics shares in Q1 2026, an estimated $105K.
Israel Englander first reported a position in Applied Therapeutics in Q2 2019 and held it in 24 quarters.
Israel Englander's Applied Therapeutics position peaked at $6.3M in Q1 2024.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.